Cuffe Michael S., EVP and Chief Clinical Officer at HCA Healthcare ($HCA), sold shares on the open market twice in the last year, totaling $2.35 million. His most recent sale occurred on February 3, 2026. These sales rank 3,164th among 11,678 insiders in our database, where the average is $8.6 million across about 6.4 transactions per insider. Cuffe made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 10, 2026 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | F | Common Stock | 3501 | $502.05 | 32,079.9017 | 239,495,000 | 9.84% | 0.00% |
| Feb. 10, 2026 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | A | Common Stock | 9628 | $0.00 | 35,580.9017 | 239,495,000 | 37.10% | 0.00% |
| Feb. 3, 2026 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | S | Common Stock | 1500 | $498.09 | 30,002.9017 | 239,495,000 | 4.76% | 0.00% |
| Feb. 3, 2026 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | G | Common Stock | 4050 | $0.00 | 25,952.9017 | 239,495,000 | 13.50% | 0.00% |
| Jan. 29, 2026 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | A | Stock Appreciation Right | 8067 | $0.00 | 8,067.0000 | 239,495,000 | 9999.99% | 0.00% |
| Sept. 8, 2025 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | S | Common Stock | 3836 | $418.84 | 31,502.9017 | 261,805,999 | 10.85% | 0.00% |
| Sept. 4, 2025 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | M | Common Stock | 10920 | $173.12 | 42,422.9017 | 261,805,999 | 34.66% | 0.00% |
| Sept. 4, 2025 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | M | Stock Appreciation Right | 10920 | $0.00 | 10,000.0000 | 261,805,999 | 52.20% | 0.00% |
| Sept. 4, 2025 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | F | Common Stock | 7084 | $411.59 | 35,338.9017 | 261,805,999 | 16.70% | 0.00% |
| Feb. 13, 2025 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | A | Common Stock | 2330 | $0.00 | 32,008.2085 | 261,805,999 | 7.85% | 0.00% |
| Feb. 13, 2025 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | F | Common Stock | 583 | $321.92 | 31,425.2085 | 261,805,999 | 1.82% | 0.00% |
| Jan. 28, 2025 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | A | Stock Appreciation Right | 11171 | $0.00 | 11,171.0000 | 261,805,999 | 9999.99% | 0.00% |
| Sept. 10, 2024 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | M | Stock Appreciation Right | 22080 | $0.00 | 0.0000 | 276,412,000 | 100.00% | 0.01% |
| Sept. 10, 2024 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | M | Common Stock | 22080 | $145.24 | 51,758.2085 | 276,412,000 | 74.40% | 0.01% |
| Sept. 10, 2024 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | F | Common Stock | 13722 | $386.43 | 38,036.2085 | 276,412,000 | 26.51% | 0.00% |
| Sept. 12, 2024 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | S | Common Stock | 8358 | $385.42 | 29,678.2085 | 276,412,000 | 21.97% | 0.00% |
| May 9, 2024 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | S | Common Stock | 6311 | $316.88 | 29,623.9692 | 276,412,000 | 17.56% | 0.00% |
| May 8, 2024 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | G | Common Stock | 4500 | $0.00 | 35,934.9692 | 276,412,000 | 11.13% | 0.00% |
| May 7, 2024 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | M | Stock Appreciation Right | 18660 | $0.00 | 0.0000 | 276,412,000 | 100.00% | 0.01% |
| May 7, 2024 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | F | Common Stock | 12349 | $314.45 | 40,434.9692 | 276,412,000 | 23.40% | 0.00% |
| May 7, 2024 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | M | Common Stock | 18660 | $139.06 | 52,783.9692 | 276,412,000 | 54.68% | 0.01% |
| May 6, 2024 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | S | Common Stock | 1600 | $309.00 | 34,123.9692 | 276,412,000 | 4.48% | 0.00% |
| Feb. 16, 2024 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | F | Common Stock | 6212 | $308.55 | 35,696.9672 | 276,412,000 | 14.82% | 0.00% |
| Feb. 16, 2024 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | A | Common Stock | 12560 | $0.00 | 37,488.9672 | 276,412,000 | 50.38% | 0.00% |
| Feb. 16, 2024 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | A | Common Stock | 4420 | $0.00 | 41,908.9672 | 276,412,000 | 11.79% | 0.00% |
| Jan. 31, 2024 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | A | Stock Appreciation Right | 12656 | $0.00 | 12,656.0000 | 276,412,000 | 9999.99% | 0.00% |
| Jan. 31, 2024 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | S | Common Stock | 3200 | $306.79 | 24,928.9672 | 276,412,000 | 11.38% | 0.00% |
| Jan. 31, 2024 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | G | Common Stock | 728 | $0.00 | 28,128.9672 | 276,412,000 | 2.52% | 0.00% |
| April 28, 2023 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | S | Common Stock | 12556 | $284.44 | 28,783.3569 | 294,666,000 | 30.37% | 0.00% |
| April 24, 2023 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | M | Common Stock | 32020 | $101.16 | 60,803.3569 | 294,666,000 | 111.24% | 0.01% |
| April 24, 2023 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | M | Stock Appreciation Right | 32020 | $0.00 | 0.0000 | 294,666,000 | 100.00% | 0.01% |
| April 24, 2023 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | F | Common Stock | 19464 | $286.25 | 41,339.3569 | 294,666,000 | 32.01% | 0.01% |
| Feb. 17, 2023 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | A | Common Stock | 12160 | $0.00 | 32,982.5543 | 294,666,000 | 58.40% | 0.00% |
| Feb. 17, 2023 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | F | Common Stock | 4232 | $262.84 | 28,750.5543 | 294,666,000 | 12.83% | 0.00% |
| Feb. 1, 2023 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | S | Common Stock | 4000 | $257.11 | 20,822.5543 | 294,666,000 | 16.11% | 0.00% |
| Oct. 31, 2022 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | G | Common Stock | 450 | $0.00 | 24,822.5543 | 0 | 1.78% | 0.00% |
| Jan. 30, 2023 | HCA Healthcare, Inc. | $HCA | Cuffe Michael S. | EVP and Chief Clinical Officer | A | Stock Appreciation Right | 14524 | $0.00 | 14,524.0000 | 294,666,000 | 9999.99% | 0.00% |